References
- Song K, Musci T, Caughey AB. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high risk women based on a U.S. population. J Matern Fetal Neonatal Med 2013;26:1180--5
- Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012;32:1225–32
- Sahota DS, Leung WC, Chan WP, et al. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme. Hong Kong Med J 2013;19:101–8
- Cuckle H, Benn P. Multianalyte maternal serum screening for chromosomal defects. In: Milunsky A, Milunsky JM, eds. Genetic disorders and the fetus: diagnosis, prevention and treatment. 6th ed. Baltimore: Johns Hopkins University Press; 2010:771–818
- Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2010. Natl Vital Stat Rep 2012;61:1–72